Drug Database
Back to search

Czechia· CZ-0282265

APREMILAST BELUPO

A apremilast product containing apremilast, registered in Czechia by BELUPO lijekovi i kozmetika, d.d., Koprivnica. The same ATC class is registered in 18 of our 19 countries.

ATC L04AA32

Checked against SÚKL (Czech Republic) on

Informational only — not a medical device.

SOURCE REGISTER · CZSÚKL (Czech Republic)normalisedAPREMILAST BELUPOATCL04AA32REGISTER NO.CZ-0282265PACKS LISTED0CHECKEDSeptember 28, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about apremilastAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Apremilast is registered in 18 of 19 countries.

Countries holding a registration under ATC L04AA32 (apremilast), each read from that country’s own register.

  • This record: Czechia, from SÚKL (Czech Republic)
  • 10 of them publish a price we can compare per daily dose
Search apremilast products by name

Apremilast · ATC L04AA32

18 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Sweden
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of apremilast costs, country by country.

Normalised to the WHO defined daily dose (60 mg), the median price runs from $13.92 in Switzerland to $51.51 in Italy — a ×3.7 gap.

  • Czechia: $51.22 per daily dose (median across products in the class)
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Apremilast · price per daily dose (60 mg)

USD · FX 28 Sept 2026

  • IT Italy$51.51
  • CZ Czechia$51.22
  • FR France$22.59
  • CH Switzerland$13.92
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

SÚKL (Czech Republic)
Active substance
APREMILAST
Manufacturer
BELUPO lijekovi i kozmetika, d.d., Koprivnica
Country
Czechia (CZ)
ATC code
L04AA32
ATC class
Apremilast
Defined daily dose
60 mg, O
Reimbursed
Not published by this register
Source register
SÚKL (Czech Republic)
Last checked
September 28, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

82 interactions on record for apremilast.

Graded by severity as the source publishes them — 11 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check apremilast against other medicinesHow interaction checks work

Apremilast · interactions on record

82 records

  • 11 severe
  • 69 moderate
  • 2 minor

Most severe, free to view

  • RifampicinJ04AB02severe
  • MitotaneL01XX23severe
  • EnzalutamideL02BB04severe
  • ApalutamideL02BB05severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same class

Other records under L04AA32

Apremilast, as other registers publish it.

All apremilast products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of SÚKL (Czech Republic). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b64449b0-eb72-49d6-8592-072f3dbd2506
GET /v1/drugs/b64449b0-eb72-49d6-8592-072f3dbd2506?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "TBL FLM",
  "source": "sukl",
  "strength": "30MG",
  "pack_size": "56 II",
  "substance": "APREMILAST",
  "cz_kod_sukl": "0282265",
  "product_type": "CH",
  "substance_codes": "17934",
  "registration_state": "R",
  "registration_number": "59/552/24-C"
}
API referenceMCP serverPlans

See everything about apremilast.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console